S. William Tam

4.5k total citations · 1 hit paper
84 papers, 3.6k citations indexed

About

S. William Tam is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, S. William Tam has authored 84 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 34 papers in Cellular and Molecular Neuroscience and 21 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in S. William Tam's work include Pharmacological Receptor Mechanisms and Effects (27 papers), Receptor Mechanisms and Signaling (26 papers) and Neuropeptides and Animal Physiology (24 papers). S. William Tam is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (27 papers), Receptor Mechanisms and Signaling (26 papers) and Neuropeptides and Animal Physiology (24 papers). S. William Tam collaborates with scholars based in United States, China and Poland. S. William Tam's co-authors include Leonard Cook, Manuel Worcel, Rémi Quirion, JoséM. Musacchio, Yossef Itzhak, J.L. Junien, Wayne D. Bowen, Richard B. Rothman, Duncan P. Taylor and Michael L. Sabolinski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Gastroenterology.

In The Last Decade

S. William Tam

80 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A proposal for the classification of sigma binding sites

1992 689 citations S. William Tam et al. profile →

Peers

Countries citing papers authored by S. William Tam

Since Specialization

Citations

This map shows the geographic impact of S. William Tam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. William Tam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. William Tam more than expected).

Fields of papers citing papers by S. William Tam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. William Tam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. William Tam. The network helps show where S. William Tam may publish in the future.

Co-authorship network of co-authors of S. William Tam

This figure shows the co-authorship network connecting the top 25 collaborators of S. William Tam. A scholar is included among the top collaborators of S. William Tam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. William Tam. S. William Tam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	G-Protein Beta-3 Subunit Genotype Predicts Enhanced Benefit of Fixed-Dose Isosorbide Dinitrate and Hydralazine 2014 ·JACC Heart Failure ·Dennis M. McNamara, Anne L. Taylor, S. William Tam, Manuel Worcel, Clyde W. Yancy, Karen Hanley‐Yanez, Jay N. Cohn, Arthur M. Feldman	29
2	Effect of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in Elderly Patients in the African-American Heart Failure Trial 2012 ·Journal of Cardiac Failure ·(unknown), Michael L. Sabolinski, S. William Tam, Susan Ziesche, Jalal K. Ghali, W. Tad Archambault, Manuel Worcel, Jay N. Cohn	11
3	FACTORS LEADING TO 30 DAY READMISSION FOLLOWING HOSPITALIZATION FOR HEART FAILURE 2010 ·Journal of the American College of Cardiology ·Jalal K. Ghali, (unknown), (unknown), (unknown), (unknown), Ramanjit Kaur, (unknown), (unknown), Phillip D. Levy, S. William Tam, (unknown)	4
4	The Critical Link of Hypervolemia and Hyponatremia in Heart Failure and the Potential Role of Arginine Vasopressin Antagonists 2010 ·Journal of Cardiac Failure ·Jalal K. Ghali, S. William Tam	36
5	Exploring the Potential Synergistic Action of Spironolactone on Nitric Oxide–Enhancing Therapy: Insights From the African-American Heart Failure Trial 2008 ·Journal of Cardiac Failure ·Jalal K. Ghali, S. William Tam, Michael L. Sabolinski, (unknown), JoAnn Lindenfeld, Jay N. Cohn, Manuel Worcel	8
6	Lack of Bioequivalence between Different Formulations of Isosorbide??Dinitrate and Hydralazine and??the??Fixed-Dose Combination of??Isosorbide Dinitrate/Hydralazine 2007 ·Clinical Pharmacokinetics ·S. William Tam, Michael L. Sabolinski, Manuel Worcel, Milton Packer, Jay N. Cohn	14
7	Isosorbide Dinitrate and Hydralazine in a Fixed-Dose Combination Produces Further Regression of Left Ventricular Remodeling in a Well-Treated Black Population With Heart Failure: Results From A-HeFT 2007 ·Journal of Cardiac Failure ·Jay N. Cohn, S. William Tam, Inder S. Anand, Anne L. Taylor, Michael L. Sabolinski, Manuel Worcel	53
8	Aldosterone Synthase Promoter Polymorphism Predicts Outcome in African Americans With Heart Failure 2006 ·Journal of the American College of Cardiology ·Dennis M. McNamara, S. William Tam, Michael L. Sabolinski, (unknown), Karen Janosko, Anne L. Taylor, Jay N. Cohn, Arthur M. Feldman, Manuel Worcel	69
9	Outcomes by Gender in the African-American Heart Failure Trial 2006 ·Journal of the American College of Cardiology ·Anne L. Taylor, JoAnn Lindenfeld, Susan Ziesche, Mary Norine Walsh, Judith E. Mitchell, Kirkwood F. Adams, S. William Tam, Elizabeth Ofili, Michael L. Sabolinski, Manuel Worcel, Jay N. Cohn	42
10	Influence of Blood Pressure on the Effectiveness of a Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine in the African-American Heart Failure Trial 2006 ·Journal of the American College of Cardiology ·Inder S. Anand, S. William Tam, Thomas S. Rector, Anne L. Taylor, Michael L. Sabolinski, W. Tad Archambault, Kirkwood F. Adams, Adeoye Y. Olukotun, Manuel Worcel, Jay N. Cohn	47
11	Enhanced gastroprotective and anti-ulcerogenic activities in rats of a new class of proton pump inhibitor containing nitrosothiol nitric oxide donor 2001 ·Gastroenterology ·J. K. Saha, (unknown), (unknown), (unknown), (unknown), David S. Garvey, L. Gordon Letts, M. Michael Wolfe, S. William Tam	4
12	Structure–activity studies on 4-substituted-2-anilinopyrimidine corticotropin releasing factor (CRF) antagonists 1999 ·Bioorganic & Medicinal Chemistry ·Paul J. Gilligan, Liqi He, Steven Culp, Lawrence W. Fitzgerald, S. William Tam, Y. Nancy Wong	8
13	3-Substituted 3-(4-pyridinylmethyl)-1,3-dihydro-1-phenyl-2H-indol-2-ones as acetylcholine release enhancers: synthesis and SAR 1993 ·Journal of Medicinal Chemistry ·(unknown), (unknown), S. William Tam	9
14	Selective reversible and irreversible ligands for the .kappa. opioid receptor 1992 ·Journal of Medicinal Chemistry ·Chen Cheng, Sarah J. Wu, Ling‐Wei Hsin, S. William Tam	17
15	Further studies on the selectivity of DuP 753, a nonpeptide angiotensin II receptor antagonist 1991 ·European Journal of Pharmacology ·Pancras C. Wong, S. William Tam, William F. Herblin, Pieter B.M.W.M. Timmermans	18
16	Synthesis of (1′, 2′-trans)-3-phenyl-1-[2′-(N-pyrrolidinyl)cyclohexyl]-pyrrolid-2-ones as κ-selective opiates 1990 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), (unknown), S. William Tam	13
17	DuP 996 (3,3‐bis(4‐pyrindinylmethyl)‐1‐phenylindolin‐2‐one) enhances the stimulus‐induced release of acetylcholine from rat brain in vitro and in vivo 1990 ·Drug Development Research ·Victor J. Nickolson, S. William Tam, (unknown), Leonard Cook	68
18	σ and PCP receptors in human frontal cortex membranes 1988 ·European Journal of Pharmacology ·S. William Tam, (unknown)	31
19	Discriminative stimulus properties of a σ receptor agonist in the rat: role of monoamine systems 1987 ·European Journal of Pharmacology ·George F. Steinfels, S. William Tam, Leonard Cook	8
20	Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. 1986 ·Journal of Pharmacology and Experimental Therapeutics ·S. William Tam, Lee‐Yuan Liu‐Chen	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact